Search results
Results from the WOW.Com Content Network
Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous system. It is an extremely rare condition, affecting as few as 1 in 10,000,000 people per year.
Myoclonus is a brief, involuntary, irregular (lacking rhythm) twitching of a muscle, a joint, or a group of muscles, different from clonus, which is rhythmic or regular. Myoclonus (myo-"muscle", clonus "spasm") describes a medical sign and, generally, is not a diagnosis of a disease.
Myoclonic dystonia or Myoclonus dystonia syndrome is a rare movement disorder that induces spontaneous muscle contraction causing abnormal posture. The prevalence of myoclonus dystonia has not been reported, however, this disorder falls under the umbrella of movement disorders which affect thousands worldwide. [ 1 ]
Opsoclonus myoclonus syndrome: Central nervous system, eye movement control Anti-neuronal antibodies Possible [105] Optic neuritis: Optic nerve Various Confirmed [106] Scleritis: Sclera: Various Possible [107] Susac's syndrome: Retina, cochlea, and brain None specific Probable [108] Sympathetic ophthalmia: Uveal tract: Various Probable Rare [109]
Myoclonus: 333.2 G25.3 Chorea (rapid, involuntary movement) Drug induced chorea: G25.4 Drug-induced tics and tics of organic origin 333.3 G25.6 Paroxysmal nocturnal limb movement G25.80 Painful legs (or arms), moving toes (or fingers) syndrome G25.81 Sporadic restless leg syndrome: G25.82 Familial restless leg syndrome G25.83 Stiff-person ...
Lance–Adams syndrome (LAS) is a sequela of hypoxic encephalopathy due to respiratory arrest, airway obstruction, cardiac arrest, etc., several days after the onset of hypoxic encephalopathy. A condition that presents with functional myoclonus associated with increased cortical excitability in a few weeks.
MEAK is a form of progressive myoclonus epilepsy that typically begins between the ages of 3 and 15 years (the average of onset is 10 years). The first symptoms may include ataxia and myoclonus (unsteadiness and difficulty coordinating movements), along with generalized tonic-clonic ("grand mal") seizures.
Progressive myoclonus epilepsy is a disease associated with myoclonus, epileptic seizures, and other problems with walking or speaking. These symptoms often worsen over time and can be fatal. [6] MERRF syndrome is also known as myoclonic epilepsy with ragged-red fibers.